On 19 July, the Innovative Medicines Initiative (IMI) launched two new Calls for proposals with topics on Alzheimer’s disease, among others. The total budget for the two Calls stands at just over EUR 130 million.
EPAD is very pleased to announce that the The EPAD Longitudinal Cohort Study (EPAD-LCS) has begun Wave 2 of its TDCs, with centres opening for recruitment in San Sebastian (Spain) and Stockholm (Sweden).
It is with great sadness that we share the news that Professor Dieter Ferring died unexpectedly, on 3 August. He would have turned 60 next year. We would like to extend our heartfelt condolences to his family, friends and colleagues.
During July and August 2017, Alzheimer Europe (AE) has added more clinical trials to its Clinical Trials Watch (CTW) – a service with up-to-date, accessible information.
You can register for the 27th Alzheimer Europe Conference (#27AEC) in Berlin until 22 September. Special rates are available for people with dementia, students, delegates from lower and middle-income countries and members of Deutsche Alzheimer Gesellschaft regional branches.
This newsletter received funding under an operating grant from the European Union’s Health Programme (2014-2020).
The content of this newsletter represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.